Key issues covered during the audit include

• Regulatory Compliance: Ensure adherence to FDA, EMA, ICH, GCP, and GLP guidelines.
• Study Design and Methodology: Review study design, analytical methods, and equipment validation.
• Quality Management Systems: Verify robust QMS and SOPs for consistency and data integrity.
• Data Integrity and Management: Ensure proper data validation, security, and backup protocols.
• Infrastructure and Equipment: Audit laboratory facilities and equipment maintenance.
• Personnel and Training: Assess qualifications and training programs for staff.
• Audit History and Corrective Actions: Review previous audit findings and corrective measures.
• Ethical Compliance and Patient Safety: Ensure adherence to ethical guidelines and patient safety protocols.
• Risk Management: Evaluate risk management strategies for study execution.
• Ongoing Monitoring: Conduct regular audits to maintain compliance and performance standards.

Detailed Audit Agenda is prepared before the Audit. CRQA also follows the Sponsor Checklist and is covered during the audit.

This audit ensures that CROs maintain high standards in conducting BA/BE studies, providing confidence in their results and regulatory compliance.

BA/BE Study Monitoring Services

CRQA BA/BE Study Monitoring Services ensure that bioavailability and bioequivalence studies are conducted according to regulatory standards, maintaining data integrity and compliance at every stage.

CRQA BA/BE Study Monitoring

• Study Design and Setup: Ensure study design meets regulatory and industry standards.
• Protocol Adherence: Monitor compliance with the approved study protocol.
• Data Integrity and Quality Control: Ensure accurate and reliable data collection.
• Regulatory Compliance: Adhere to FDA, EMA, ICH, and local regulations.
• Site Monitoring and Audits: Regular site visits to ensure protocol adherence and identify issues.
• Risk Management and Issue Resolution: Identify and mitigate risks early in the study.
• Reporting and Documentation: Ensure accurate reporting and maintain thorough documentation.
• Training and Support: Provide ongoing training and support to study sites.
• Final Study Report: Prepare a compliant and accurate final report for regulatory submission.

These services ensure high-quality, compliant BA/BE studies, leading to successful regulatory submissions.

CRQA BA/BE Study Audits Services ensure that bioavailability and bioequivalence studies meet regulatory standards, maintaining data integrity and compliance throughout the study process.

CRQA Approach for Study Audits

• Protocol Compliance Audit: Verify adherence to the approved study protocol and identify any deviations.
• Regulatory Compliance Verification: Ensure compliance with global regulations (FDA, EMA, ICH) and ethical guidelines.
• Data Integrity and Accuracy: Audit data collection and handling processes to ensure accuracy and integrity.
• Site Monitoring and Documentation Review: Conduct on-site audits to review documentation, sample handling, and GCP/GLP adherence.
• Quality Management Systems (QMS): Review SOPs and systems to ensure consistency and compliance.
• Adverse Event Reporting: Audit the reporting and documentation of adverse events.
• Audit Findings and Corrective Actions: Identify non-compliance and implement corrective actions.
• Final Study Audit and Reporting: Perform final audits and prepare detailed reports for regulatory submission.